To determine if GITR expression can also have effect on Bortezomib-induced MM tumor growth inhibition in mice model, we assessed the tumor growth upon the treatment of Bortezomib in MM1.S xenograft immune deficiency mice by tail vein injection. The gene discussed is TNFRSF18; the disease is Miyoshi myopathy.